Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 1, 2010

Bruker Sets Up Chemical Analysis Division

  • Bruker has created a Chemical Analysis Division within its Bruker Daltonics subsidiary. Varian product lines to be acquired from Agilent will become part of this segment. This includes ICP-MS systems, laboratory gas chromatography (GC) instruments, and GC-triple-quadrupole mass spectrometers.

    Bruker inked a deal with Agilent on March 9 for the Varian devices. Agilent was forced to divest the products to obtain regulatory approval for its acquisition of Varian. “We look forward to welcoming the customers of these three product lines, and we are committed to providing the highest level of applications and service support as well as accelerated applications and product development to this valued customer base,” comments Collin D’Silva, the new president of the Bruker Chemical Analysis Division. The segment will be headquartered in Fremont, CA.

    “These three businesses offer an opportunity to leverage our existing strengths in the analytical instruments market,” adds Frank Laukien, president and CEO of Bruker. “The three new product lines will form the core offerings of our new Chemical Analysis Division.”



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »